Name: GLP-3 RETA
SKU: 10240131858762
Price: 94.99 GBP
Availability: InStock

Home Featured GLP-3 RETA

CAGRILINTIDE

£49.99

BPC-157

£34.99

GLP-3 RETA

~~£120.00~~ £94.99

GLP-3 RETA (Retatrutide) – Advanced Metabolic Peptide Research15mg Vial | Ultra-Pure | ≥99% Peptide-Grade Purity🔬 High-Purity Research Peptide – Synthesized for reproducible laboratory studies🧪 Verified for Quality – HPLC Tested, COA Provided, Third-Party Tested📚 Backed by Scientific Literature – Extensive studies on metabolic regulation, weight management, and GLP receptor research...

Special Offer

In Stock
Free delivery available*
Sale 20% Off Use Code: XMAS2025

mg

10mg

20mg

30mg

50mg

SKU :

Why Choose Us ?

Maxx Labs delivers trusted quality, expert support, and reliable service—so your research stays precise, professional, and on track.

Returns

All products are sold strictly for research use. Returns are only accepted if items arrive damaged, defective, or incorrect—please contact us within 7 days of delivery.

Shipping

We offer next working day UK shipping for £4.99. Orders over £100 qualify for free shipping—fast, reliable delivery every time.

GLP-3 RETA (Retatrutide) – Advanced Metabolic Peptide Research
15mg Vial | Ultra-Pure | ≥99% Peptide-Grade Purity
🔬 High-Purity Research Peptide – Synthesized for reproducible laboratory studies
🧪 Verified for Quality – HPLC Tested, COA Provided, Third-Party Tested
📚 Backed by Scientific Literature – Extensive studies on metabolic regulation, weight management, and GLP receptor research

Chemical Information
• Synonyms: Retatrutide, GLP-3 RETA
• Form: Lyophilized powder, 10mg, 20mg, 30mg, 50mg per vial
• Purity: ≥99% (Peptide-grade)
• Storage: Store at 2–8°C in a dry, shaded place

Description
GLP-3 RETA is a next-generation peptide targeting GLP-1, Glucagon, and GIP receptors for research into metabolic regulation and body composition. Retatrutide has shown preclinical potential to regulate appetite, enhance fat metabolism, and support weight management studies. Its multi-receptor activity makes it a leading candidate for studies alongside other metabolic peptides.

Used in preclinical studies, GLP-3 RETA complements peptides like Tesamorelin, 5 AMINO 1MQ, and MAXX SHRED for enhanced metabolic and fat-loss research protocols.

Research Findings & Scientific Insights
🧪 Metabolic Regulation: Preclinical studies demonstrate effects on glucose homeostasis, appetite control, and energy expenditure.
⚖️ Body Composition: Enhances fat metabolism pathways, supporting lean mass maintenance.
🌐 Multi-Receptor Activity: Triple GLP-1, GIP and Glucagon receptor activation for synergistic metabolic effects.

Product Assurance
✅ HPLC Verified – Ensuring ≥99% purity
✅ COA Provided – On Request
✅ Manufactured in a GMP-Certified Facility - Developed & Dispatched in the UK
✅ Third-Party Testing Available
✅ Cold Chain Express Delivery – Ensuring Potency & Integrity

⚠️ For Research Use Only
GLP-3 RETA is supplied strictly for scientific research purposes. Not approved for human or veterinary use. Handle with appropriate lab safety procedures.

⚠️ For Research Use Only – Not for Human Consumption
This product is intended strictly for laboratory research purposes and is not approved for human or veterinary use, therapeutic application, or diagnostic procedures. All handling must be performed by trained professionals in compliance with appropriate laboratory safety protocols and applicable regulations.

18+ Notice: This material is not for sale to individuals under the age of 18. By purchasing, you confirm that you are a qualified individual or acting on behalf of a qualified institution, and that the compound will be used exclusively for legitimate scientific investigation.

We acknowledge that in certain regions—particularly in countries outside of the United Kingdom, where manufacturing oversight and regulatory enforcement may be less stringent—there are isolated cases of individuals attempting to self-administer research compounds. We strongly discourage and explicitly warn against any such misuse. The self-experimentation of unapproved substances carries significant, unquantifiable risks and is both medically irresponsible and ethically unsound. Without proper analytical validation, GMP-level controls, and clinical context, the safety, quality, and pharmacological reliability of these materials cannot be assured.

All compounds must be handled in secure, controlled environments by competent personnel. Any deviation from these principles is contrary to responsible research practice and breaches both our terms of sale and the intended scientific use of these products.